Roi Finish
Co-Founder & CEO
17+ years in MedTech. Previously Johnson & Johnson and Dentsply Sirona.
Investigational device · For research use only
Swiss MedTech · Optical Polarimetric Imaging
The Future of Intraoperative Tissue Imaging
PolaSight is developing PolaOne, an optical polarimetric imaging platform designed to support real-time tissue assessment within the intraoperative pathology workflow.
Fig. 1 · PolaOne — Benchtop polarimetric imaging platform
Est. 2024·Lausanne, Switzerland·Spinoff — University of Bern, ARTORG
ScrollThe Challenge
A Clinical Bottleneck That Hasn't Changed in 130 Years
01
During cancer surgery, the pathology team is asked to deliver immediate insight into tissue that has just been removed. Today, that insight depends on rapid frozen section - a technique that is slow, destructive, and limited in scope.
02
The result is prolonged decision-making, pressure on the pathology lab, and tissue specimens that are partially consumed before they reach modern molecular workflows.
03
PolaSight is working to support the intraoperative pathology team with a faster, non-destructive imaging tool that integrates into their existing workflow.
The Solution
PolaOne: Optical Polarimetry for the Pathology Lab
PolaOne is a compact benchtop scanner that images fresh tissue specimens immediately after resection. No freezing. No staining. No tissue destruction.
Built on years of academic research at the University of Bern, PolaOne combines optical polarimetric imaging with advanced computational methods to produce visual maps of tissue properties for pathologist review.
01
Fast
Designed for rapid scanning that fits the pace of intraoperative consultation.
02
Non-Destructive
Tissue is preserved intact for all downstream pathology and molecular workflows.
03
Computationally Enhanced
Polarimetric data is processed to generate intuitive visual maps for the pathologist.
04
Pathology Workflow-Integrated
Engineered to fit within the existing intraoperative pathology consultation process, not replace it.
Fig. 2 · Polarimetric tissue map · Representative output
Origin
A Swiss Deep-Tech Spin-Out
PolaSight is a spin-out from the ARTORG Center for Biomedical Engineering Research at the University of Bern, building on more than a decade of academic research in biomedical optics and computational imaging.
The company is headquartered in Lausanne, Switzerland.
Recognition
Backed by Swiss Innovation
Supported by leading European MedTech ecosystems
Team
A Team Built at the Intersection of Optics, AI, and MedTech
Davide Scandella
Co-Founder & CTO
Optical systems engineering and polarimetry hardware. ARTORG Center, University of Bern.
Dr. Pablo Márquez Neila
Co-Founder & CSO
15+ years in computational imaging and machine learning. ARTORG Center, University of Bern.
Prof. Dr. Raphaël Sznitman
Co-Founder & Scientific Advisor
Director, ARTORG Center, University of Bern. Previous founder of RetinAI (acquired).
Get in Touch
Interested in PolaSight?
We are developing PolaOne with a focus on clinical impact, scientific rigor, and regulatory discipline. If you are a pathologist, clinician, hospital partner, researcher, or aligned investor and would like to learn more, we'd be glad to hear from you.
Location
Lausanne, Switzerland